Dana Farber Cancer Institute at Milford Regional Medical Center — Milford, Massachusetts

Dana Farber Cancer Institute at Milford Regional Medical Center is a clinical research site located in Milford, Massachusetts, United States 01757.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute at Milford Regional Medical Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.

Sponsors: Dana-Farber Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Milford

Browse all research sites in Massachusetts · View every site in Milford

• DFCI @ Milford Regional Hospital
• Dana-Farber Brigham Cancer Center, Milford Hospital
• Milford Hospital
• Dana Farber Cancer Institute @ Milford Regional Hospital
• Dana-Farber Cancer Institute at Milford Hospital
• Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
• GSK Investigational Site
• Pfizer Investigational Site
• Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
• Dana-Farber at Milford
• Milford Emergency Associates, Inc
• DF/BWCC at Milford Regional Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute at Milford Regional Medical Center?

Dana Farber Cancer Institute at Milford Regional Medical Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute at Milford Regional Medical Center conducted?

Dana Farber Cancer Institute at Milford Regional Medical Center has 1 clinical trials on record, with 1 currently active. Their work covers Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.

Is Dana Farber Cancer Institute at Milford Regional Medical Center accredited by Crixeo Clinical Trials?

Dana Farber Cancer Institute at Milford Regional Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute at Milford Regional Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.